SCHEMBL7223363

SCHEMBL7223363

Cc1ccc2c(c1C)N(CCCN(C)c1ccc(Cl)cc1Cl)c1cccnc1[S+]2[O-]

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 3/20 0.33
CYP1A2 P05177 3/20 0.33
CYP3A4 P08684 3/20 0.33
HTR1A P08908 3/20 0.33
CYP2D6 P10635 3/20 0.33
DRD2 P14416 3/20 0.33
MEN1 O00255 3/20 0.33
KMT2A Q03164 3/20 0.33
LMNA P02545 3/20 0.33
MAPT P10636 3/20 0.33
SMN1; SMN2 Q16637 3/20 0.33
SLC22A1 O15245 2/20 0.33
ABCB11 O95342 2/20 0.33
CHRM2 P08172 2/20 0.33
CHRM4 P08173 2/20 0.33
CHRM5 P08912 2/20 0.33
ADRA2A P08913 2/20 0.33
ADORA3 P0DMS8 2/20 0.33
CHRM1 P11229 2/20 0.33
ADRA2B P18089 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6746814 0.65
Chloropromazine Sulfoxide SCHEMBL30463300 0.62 CYP2D6 (0.62) TP53CYP1A2CYP3A4HTR1ACYP2D6
Chloropromazine Sulfoxide SCHEMBL1155596 0.62 CYP2D6 (0.62) TP53CYP1A2CYP3A4HTR1ACYP2D6
Chloropromazine Sulfoxide SCHEMBL31540233 0.62 CYP2D6 (0.62) TP53CYP1A2CYP3A4HTR1ACYP2D6
Chloropromazine Sulfoxide SCHEMBL9724483 0.61 LMNA (0.63) TP53CYP1A2CYP3A4HTR1ACYP2D6
SCHEMBL6746847 0.61 HTR2A (0.41) HTR2ATDP1
SCHEMBL10925157 0.60 CYP2D6 (0.62) TP53CYP1A2CYP3A4HTR1ACYP2D6
SCHEMBL6748667 0.58 HTR2A (0.31) HTR2A
SCHEMBL6746830 0.58 ACHE (0.39) MEN1KMT2ACHRM2SIGMAR1TDP1
SCHEMBL6746868 0.58 DRD2 (0.39) CYP1A2HTR1ADRD2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6583138-B1 Mediators or antagonists of the effects of histamine, leukotriene and the like; heterocyclic ring condensed benzothiazine compounds; inhibit the activation of the tyrosine kinase of 72 kDa EISAI CO., LTD. (JP) 2003-06-24 US claimed